AC Immune SA - stock earnings
ACIU Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 3, 2024 BeforeMarket | -0.05 / -0.12 | - | - / 6.0 million | 18.8 million |
ACIU Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -5.6 million USD | 17.6 million USD |
| 2023Q3 | -16.5 million USD | ? USD |
| 2023Q2 | -18.7 million USD | ? USD |
| 2023Q1 | -19.2 million USD | ? USD |
| 2022Q4 | -20.3 million USD | 1081 USD |
| 2022Q3 | -13.9 million USD | 4.0 million USD |
| 2022Q2 | -20.6 million USD | ? USD |
| 2022Q1 | -20.4 million USD | ? USD |
| 2021Q4 | -23.3 million USD | ? USD |
| 2021Q3 | -17.1 million USD | ? USD |
| 2021Q2 | -20.6 million USD | ? USD |
| 2021Q1 | -17.7 million USD | ? USD |
| 2020Q4 | -21.7 million USD | 1.1 million USD |
| 2020Q3 | -20.6 million USD | 1.2 million USD |
| 2020Q2 | -16.6 million USD | 1.3 million USD |
| 2020Q1 | -8.0 million USD | 12.9 million USD |
| 2019Q4 | -20.1 million USD | 1.1 million USD |
| 2019Q3 | 18.4 million USD | 33.7 million USD |
| 2019Q2 | -17.3 million USD | 1.5 million USD |
| 2019Q1 | 63.9 million USD | 75.4 million USD |
| 2018Q4 | -14.9 million USD | 1.4 million USD |
| 2018Q3 | -13.8 million USD | 2.4 million USD |
| 2018Q2 | -11.2 million USD | 2.0 million USD |
| 2018Q1 | -12.1 million USD | 1.5 million USD |
| 2017Q4 | 4.3 million USD | 16.8 million USD |
| 2017Q3 | -9.1 million USD | 1.1 million USD |
| 2017Q2 | -12.9 million USD | 788272 USD |
| 2017Q1 | -9.5 million USD | 2.0 million USD |
| 2016Q4 | -4.7 million USD | 1.4 million USD |
| 2016Q3 | -9.4 million USD | 1.4 million USD |
| 2016Q2 | 13.2 million USD | 20.4 million USD |
| 2016Q1 | -6.4 million USD | 504721 USD |
| 2015Q4 | -5.7 million USD | 318819 USD |
| 2015Q3 | 20.7 million USD | 25.1 million USD |
| 2015Q2 | 9.3 million USD | 15.3 million USD |
| 2015Q1 | -3.1 million USD | 242941 USD |
| 2014Q4 | 10.9 million USD | 30.8 million USD |
ACIU Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -64.5 million USD | 17.6 million USD |
| 2022 | -76.5 million USD | 4.3 million USD |
| 2021 | -80.0 million USD | 1.0 million USD |
| 2020 | -69.1 million USD | 17.2 million USD |
| 2019 | 46.9 million USD | 114.6 million USD |
| 2018 | -51.8 million USD | 7.3 million USD |
| 2017 | -27.0 million USD | 20.7 million USD |
| 2016 | -7.0 million USD | 22.8 million USD |
| 2015 | 20.5 million USD | 39.6 million USD |
| 2014 | 10.9 million USD | 30.6 million USD |
| 2013 | -12.7 million USD | 9.7 million USD |
ACIU
Price: $2.39
52 week price:
Earnings Per Share: -0.71 USD
P/E Ratio: -3.24
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 182100
Ebitda: -8.8 millionMarket Capitalization: 232.4 million